Amarin (AMRN) Up 7% on Intellectual Property Wins in Europe

Shares of Amarin Corporation (AMRN) rose 7.1% on Wednesday after management announced positive updates on its intellectual property portfolio for its sole marketed drug, Vazkepa, in Europe.Amarin obtained a new patent covering Vazkepa from the European Patent Office (EPO). The latest patent adds another eight years to the drug’s regulatory exclusivity in Europe, extending the commercial protection across the continent till April 2039.Along with the above news, management succeeded in defending another one o ...